SCHEMBL4897248

SCHEMBL4897248

C=CCOC(=O)c1cnn(-c2nccs2)c1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.46
ALDH1A1 P00352 7/20 0.46
HPGD P15428 6/20 0.46
MAPT P10636 6/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
GAA P10253 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
POLB P06746 2/20 0.43
TRPC1 P48995 1/20 0.39
TRPC3 Q13507 1/20 0.39
STIM1 Q13586 1/20 0.39
ORAI1 Q96D31 1/20 0.39
STIM2 Q9P246 1/20 0.39
CYP3A4 P08684 1/20 0.37
RAB9A P51151 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7157437 0.89 KDM4E (0.40) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL12890284 0.85 HPGD (0.60) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL4890364 0.83 MAPT (0.42) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL4866456 0.79 MAPT (0.56) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL4896499 0.72 SNCA (0.40) ALDH1A1MAPTMEN1KMT2ACYP3A4
SCHEMBL12875617 0.69 MAPT (0.54) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL20265770 0.67 MALT1 (0.53) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL20265704 0.67 MALT1 (0.53) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL31094429 0.67 MALT1 (0.54) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL20265444 0.67 MALT1 (0.54) KDM4EALDH1A1HPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-20050215608-A1 Bis-aryl thiazole derivatives AMGEN INC. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215608-A1 Bis-aryl thiazole derivatives FABP4, PC, TXNRD2 KDM4E 3696/4885ALDH1A1 842/4885HPGD 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.